Duane Nash's Net Worth

-$313 Thousand

Estimate Recalculated Jul 12, 2024 07:33AM EST

Who is Duane Nash?

Duane Nash does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNIC, INC., and Akebia Therapeutics, Inc..

SEC CIK

Duane Nash's CIK is 0001591098

Past Insider Trading and Trends

2015 was Duane Nash's most active year for acquiring shares with 5 total transactions. Duane Nash's most active month to acquire stocks was the month of May. 2019 was Duane Nash's most active year for disposing of shares, totalling 9 transactions. Duane Nash's most active month to dispose stocks was the month of December. 2014 saw Duane Nash paying a total of $824,390.44 for 71,386 shares, this is the most they've acquired in one year. In 2014 Duane Nash cashed out on 35,799 shares for a total of $402,104.34, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNIC, INC. (IMUX) Snapshot price: $1.22

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 15
Form 4
+33.24%
4K
$5.03
$50,300.00
16.03K
May 12
Form 4
—
0
—
—
0
Mar 10
Form 4
+7.13%
1K
$9.80
$9,800.00
15.03K
Aug 10
Form 4
—
0
—
—
0
Jun 10
Form 4
+39.87%
4K
$12.75
$51,000.00
14.03K
May 12
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Oct 22
Form 4
—
0
—
—
0
Jul 2
Form 4
+4,793.66%
9.83K
$7.08
-$87,356.01
10.03K
Scheduled
Dec 2 - Dec 4
Form 4
—
0
—
—
0
Jul 22
Form 4
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 10
Form 4
+90.19%
3.9K
$3.12
$12,182.04
8.22K
Jun 8
Form 4
—
0
—
—
0
May 13
Form 4
+1.08%
100
$17.50
$1,750.00
9.32K
Oct 8
Form 3
—
0
—
—
0
No matching records found

Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
-4.44%
-1.00K
$14.62
-$14,620.00
21.5K
Scheduled
Feb 15
Form 4
-5.02%
-1.19K
$19.64
-$23,332.32
22.5K
Scheduled
Oct 2
Form 4
-4.01%
-990.00
$14.27
-$14,127.30
23.69K
Scheduled
Jul 3
Form 4
—
0
—
—
0
Jun 15
Form 4
-3.86%
-991.00
$9.20
-$9,119.28
24.68K
Scheduled
Apr 3
Form 4
-7.16%
-1.98K
$10.46
-$20,711.00
25.67K
Scheduled
Jan 3
Form 4
-6.69%
-1.98K
$8.96
-$17,746.00
27.65K
Scheduled
Oct 3
Form 4
-6.26%
-1.98K
$7.48
-$14,818.52
29.63K
Scheduled
Jul 6
Form 4
—
0
—
—
0
Jun 16
Form 4
-3.05%
-1.00K
$8.65
-$8,617.29
31.61K
Scheduled
Oct 2
Form 4
-2.96%
-1.00K
$9.53
-$9,489.89
32.6K
Scheduled
Jul 2
Form 4
—
0
—
—
0
Jun 10
Form 4/A
+8.92%
984
$9.30
$9,778.05
12.02K
Scheduled
Apr 1 - Apr 2
Form 4/A
+8.33%
985
$11.55
$11,643.80
12.81K
Scheduled
Jan 1 - Jan 2
Form 4/A
∞
11.83K
$11.39
$140,178.70
11.83K
Scheduled
Dec 23 - Dec 26
Form 4
+8.92%
984
$9.30
$9,778.05
12.02K
Scheduled
Apr 1 - Apr 2
Form 4
+8.33%
985
$11.55
$11,643.80
12.81K
Scheduled
Jan 1 - Jan 2
Form 4/A
∞
11.83K
$11.39
$140,178.70
11.83K
Scheduled
Dec 23 - Dec 26
Form 4
∞
11.83K
$11.39
$140,178.70
11.83K
Scheduled
Dec 23 - Dec 26
Form 3
—
0
—
—
0
No matching records found